Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema (2017)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- DOI: 10.18240/ijo.2017.05.17
- Subjects: DIABETES MELLITUS; EDEMA MACULAR CISTOIDE; TOMOGRAFIA; DOENÇAS RETINIANAS
- Keywords: Diabetes; Macular edema; Bevacizumab; Ranibizumab; Optical coherence tomography; Central subfield foveal tickness; Diabetic retinopathy
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Ophthalmology
- ISSN: 2222-3959
- Volume/Número/Paginação/Ano: v. 10, n. 5, p. 760-764, 2017
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
WILLMANN, Gabriel et al. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema. International Journal of Ophthalmology, v. 10, n. 5, p. 760-764, 2017Tradução . . Disponível em: https://doi.org/10.18240/ijo.2017.05.17. Acesso em: 15 abr. 2026. -
APA
Willmann, G., Nepomuceno, A. B., Messias, K., Barroso, L., Scott, I. U., Messias, A. M. V., & Jorge, R. (2017). Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema. International Journal of Ophthalmology, 10( 5), 760-764. doi:10.18240/ijo.2017.05.17 -
NLM
Willmann G, Nepomuceno AB, Messias K, Barroso L, Scott IU, Messias AMV, Jorge R. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema [Internet]. International Journal of Ophthalmology. 2017 ; 10( 5): 760-764.[citado 2026 abr. 15 ] Available from: https://doi.org/10.18240/ijo.2017.05.17 -
Vancouver
Willmann G, Nepomuceno AB, Messias K, Barroso L, Scott IU, Messias AMV, Jorge R. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema [Internet]. International Journal of Ophthalmology. 2017 ; 10( 5): 760-764.[citado 2026 abr. 15 ] Available from: https://doi.org/10.18240/ijo.2017.05.17 - Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Retinal safety and efficacy of a dexamethasone biodegradable implant to treat macular edema associated to retinal vein occlusion: a phase I/II clinical trial
- Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Intravitreal autologous bone marrow derived stem cells in dry age-related macular degeneration
- Intravitreal autologous bone marrow derived stem cells in ischemic maculopathy
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
